Loading
Latest filing published 07 Aug 2026 for Sharp Therapeutics Corp., €174k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 7 August 2026, William R. Newlin disclosed a transaction of €174k in Sharp Therapeutics Corp. No broader history exists yet. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration